Consensus diagnosis and therapy of soft tissue sarcoma;Konsensus diagnose und therapie von weichteilsarkomen

Wiener Klinische Wochenschrift

Volumn 124, Issue 3-4, 2012, Pages 85-99

  Brodowicz, Thomas ^a   Amann, Gabriele ^a   Leithner, Andreas ^b   Sztankay, Arpad ^c   Kainberger, Franz ^d   Eisterer, Wolfgang ^e   Liegl Atzwanger, Bernadette ^b   Rachbauer, Franz ^f   Rath, Thomas ^a   Bergmann, Michael ^a   Funovics, Philipp T ^f   Ploner, Ferdinand ^e   Windhager, Reinhard ^f  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIV KLIN FÜR RADIODIAGNOSTIK   (Austria)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f University of Vienna   (Austria)

Author keywords

Austria; Consensus; Guidelines; Multimodality treatment; Soft tissue sarcoma

Indexed keywords

ARTICLE; AUSTRIA; CANCER DIAGNOSIS; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONSENSUS; HEALTH CARE QUALITY; HUMAN; MEDICAL SOCIETY; MEDICAL SPECIALIST; MULTIMODALITY CANCER THERAPY; SOFT TISSUE SARCOMA;

AUSTRIA; HUMANS; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; SARCOMA;

EID: 84863720834     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-011-0079-8     Document Type: Article

References (108)

1. ESMO Guidelines Working Group, Leyvraz S. Soft tissue sarcomas: ESMO clinical recommandations for diagnosis, treatment and follow-up; Ann Oncol 2007;18(Suppl. 2):ii74-6.
2. Casali PG, Blay JY. On behalf of the ESMO/CONTICANET/EUROBONET Consensus Panel of experts: Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up; Ann Oncol 2010;21(Suppl. 5):v189-v203.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009; CA Cancer J Clin 2009;59(4):225-49.
4. Wibmer C, Leithner A, Zielonke N, Sperl M, Windhager R. Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. Ann Oncol 2010;21(5):1106-11.
5. Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med 2005;353(7):701-11. (Pubitemid 41175678)
6. Coindre JM, Terrier P, Guillou L, Le Doussal V, Collin F, Ranchère D, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001;91(10):1914-26. (Pubitemid 32424119)
7. Fletcher CD. The evolving classification of soft tissue tumours: an update based on the new WHO classification; Histopathology 2006;48(1):3-12.
8. Ploner F, Zacherl J, Wrba F, Längle F, Bareck E, Eisterer W, et al. Gastrointestinal stromal tumors: Recommandations on diagnosis, therapy and follow-up care in Austria. Wien Klin Wochenschr 2009;121(23-24):780-90.
9. Froehner M, Wirth P. Etiologic factors in soft tissue sarcomas. Onkologie 2001;24(2):139-42. (Pubitemid 32449009)
10. Van Dyck P, Gielen J, Vanhoenacker F, De Schepper A. General Imaging Strategy of Soft Tissue Tumors. In: De Schepper AM (Ed.): Imaging of Soft Tissue Tumors; Springer-Verlag Berlin Heidelberg 2006;3rd Edition; page 163-166.
11. Gielen J, Ceulemans R. Ultrasound of Soft Tissue Tumors. In: De Schepper AM (Ed.): Imaging of Soft Tissue Tumors. Springer-Verlag Berlin Heidelberg 2006;3rd Edition; page 3-18.
12. Brisse H, Orbach D, Klijanienko J, Fréneaux P, Neuenschwander S. Imaging and diagnostic strategy of soft tissue tumors in children. Eur Radiol 2006;16(5):1147-64.
13. Griffith JF, Chan DP, Kumta SM, Chow LT, Ahuja AT. Does Doppler analysis of musculoskeletal soft-tissue tumours help predict tumour malignancy? Clin Radiol 2004;59(4):369-75. (Pubitemid 38404622)
14. Lakkaraju A, Sinha R, Garikipati R, Edward S, Robinson P. Ultrasound for initial evaluation and triage of clinically suspicious soft-tissue masses. Clin Radiol 2009;64(6):615-21.
15. De Schepper AM, De Beuckeleer L, Vandevenne J, Somville J. Magnetic resonance imaging of soft tissue tumors. Eur Radiol 2000;10(2):213-23.
16. Morrison WB, Dalinka MK, Daffner RH, DeSmet AA, El-Khoury GY, Kneeland JB, et al. Expert Panel on Musculosketal Imaging. Soft tissue Masses. Date of origin: 1995 Last review date: 2009; online publication; http://www.acr.org/ SecondaryMainMenuCategories/quality-safety/app-criteria/pdf/ ExpertPanelonMusculoskeletalImaging/SoftTissueMassesDoc19.aspx
17. Wu JS, Hochman MG. Soft-tissue tumors and tumorlike lesions: a systematic imaging approach. Radiology 2009;253:297-316.
18. Ward WG Sr, Rougraff B, Quinn R, Damron T, O'Connor MI, Turcotte RE, et al. Tumors masquerading as hematomas. Clin Orthop Res 2007;465:232-40. (Pubitemid 350306522)
19. Jelinek J, Malawer M, Sternheim A, Ferraro R, Beaman F, Henshaw R, et al. Clinical presentation, outcome and MR findings of soft tissue tumors presenting as hematomas. Skeletal Radiol 2009;38:399-400.
20. Christie-Large M, James SL, Tiessen L, Davies AM, Grimer RJ. Imaging strategy for detecting lung metastases at presentation in patients with soft tissue sarcomas. Eur J Cancer 2008;44(13):1841-5.
21. Reske SN, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. Eur J Nucl Med 2001;28(11):1707-23. (Pubitemid 33036116)
22. Landa J, Schwartz LH. Contemporary Imaging in Sarcoma. The Oncologist 2009;14(10):1021-38.
23. Windhager R, Hovy L, Prietzel T, von Salis-Soglio G: AWMF Leitlinie Weichteilsarkome der Deutschen Gesellschaft für Orthopädie und Orthopädische Chirurgie (DGOOC) und des Berufsverbandes der Ärzte für Orthopädie, 2002.
24. Leithner A, Windhager R. Leitlinien der Biopsie von Knochen-und Weichteiltumoren. Orthopäde 2007;36(2):167-74.
25. Leithner A, Maurer-Ertl W, Windhager R. Biopsy of bone and soft tissue tumours: hints and hazards. Recent Results Cancer Res 2009;179:3-10.
26. Fletcher C D M, Unni KK, Mertens F (Hg). WHO Classification of Tumours, Volume 5, Lyons 2002; nachzulesen auch auf der Webseite der IARC unter www.iarc.fr/en/publications/pdfs-online/pat-gen/bb5/BB5.pdf
27. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 2002;359(9314):1301-7. (Pubitemid 34310636)
28. Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996;14(3):869-77. (Pubitemid 26085532)
29. Costa J. The grading and staging of soft tissue sarcomas. In Fletcher CD, McKee PH (Hg.): Pathobiology of soft tissue tumors. Churchill Livingstone. Edinburgh 1990; pp. 221.
30. Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, et al. Reproucibility of a histopathologic grading system for adult soft tissue sarcoma; Cancer 1986;58(2):306-9.
31. Coindre JM, Terrier P, Guillou L, Le Doussal V, Collin F, Ranchère D, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sacomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001;91(10):1914-26. (Pubitemid 32424119)
32. Gustafson P, Dreinhofer KE, Rydholm A. Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand 1994;65(1):47-50. (Pubitemid 24101911)
33. Le Vay J, O'Sullivan B, Catton C, Bell R, Fornasier V, Cummings B, et al. Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys 1993;27(5):1091-9. (Pubitemid 23361590)
34. Dinges S, Budach V, Budach W, Feldmann HJ, Stuschke M, Sack H. Local recurrence of soft sarcomas in adults: a retrospective analysis of prognostic factors in 102 cases after surgery and radiation therapy. Eur J Cancer 1994;30 A (11): 1636-42. (Pubitemid 24355480)
35. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1, 041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14(5):1679-89. (Pubitemid 26134227)
36. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculosceletal sarcoma. Clin Orthop Relat Res 1980;153:106-20. (Pubitemid 11217753)
37. Malawer MM, Sugarbaker PH. Musculosceletal Cancer Surgery. Treatment of Sarcomas and Allied Diseases. Kluwer Academic Publishers 2001.
38. Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, et al. The treatment of soft-tissue sarcomas of the extremities. prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196(3):305-15. (Pubitemid 12052461)
39. Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14(3):859-68. (Pubitemid 26085531)
40. Yang JC, Chang AE, Baker AR, Sindelar W F, Danforth DN, Topalian SL, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16(1):197-203. (Pubitemid 28041599)
41. Choong PF, Petersen IA, Nascimento AG, Sim FH. Is radiotherapy important for low-grade soft tissue sarcoma of the extremity? Clin Orthop Relat Res 2001;387:191-9. (Pubitemid 32510341)
42. Jebsen N, Trovik CS, Bauer HC, Rydholm A, Monge OR, Hall KS, et al. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys 2008;71(4):1196-203.
43. Barkley HT Jr, Martin RG, Romsdahl MM, Lindberg R, Zagars GK. Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resection. Int J Radiat Oncol Biol Phys 1988;14(4):693-9.
44. Suit HD, Spiro I. Role of radiation in the management of adult patients with sarcoma of soft tissue. Semin Surg Oncol 1994;10(5):347-56. (Pubitemid 24300052)
45. O'Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359(9325):2235-41. (Pubitemid 34717977)
46. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys 2003;56(2):482-8. (Pubitemid 36542907)
47. Cheng EY, Dusenbery KE, Winters MR, Thompson RC. Soft tissue sarcomas: preoperative versus postoperative radiotherapy. J Surg Oncol 1996;61(2):90-9. (Pubitemid 26066068)
48. Davis AM, O'Sullivan B, Turcotte R, Bell R, Catton C, Chabot P, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 2005;75(1):48-53. (Pubitemid 40616794)
49. Sindelar W F, Kinsella TJ, Chen PW, De Laney TF, Tepper JE, Rosenberg SA, et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg 1993;128(4):402-10. (Pubitemid 23115380)
50. Alektiar KM, Hu K, Anderson L, Brennan MF, Harrison LB. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 2000;47(1):157-63. (Pubitemid 30179689)
51. Rachbauer F, Sztankay A, Kreczy A, Sununu T, Bach C, Nogler M, et al. High-dose-rate intraoperative brachytherapy (IOHDR) using flab technique in the treatment of soft tissue sarcomas. Strahlenther Onkol 2003;179(7):480-5. (Pubitemid 36735777)
52. Niewald M, Fleckenstein J, Licht N, Bleuzen C, Ruebe C. Intraoperative radiotherapy (IORT) combined with external beam radiotherapy (EBRT) for soft-tissue sarcomas - a retrospective evaluation of the Homburg experience in the years 1995-2007; Radiat Oncol 2009;4:32.
53. Wanebo HJ, Temple WJ, Popp MB, Constable W, Aron B, Cunningham SL. Preoperative regional therapy for extremity sarcoma. A tricenter update Cancer 1995;75(9):2299-306.
54. Sauer R, Schuchardt U, Hohenberger W, Wittekind C, Papadopoulos T, Grabenbauer GG, et al. Neoadjuvant rediochemotherapy in soft tissue sarcomas. Optimization of local functional tumor control. Strahlenther Onkol 1999;175(6):259-66. (Pubitemid 29277512)
55. De Laney TF, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ, et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 2003;56(4):1117-27. (Pubitemid 36794046)
56. Kraybill WG, Harris J, Spiro IJ, Ettinger DS, De Laney TF, Blum RH, et al. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, highgrade, soft tissue sarcomas of the extremeties and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol 2006;24(4):619-25. (Pubitemid 46630425)
57. Kepka L, De Laney TF, Suit HD, Goldberg SI. Results of radiation therapy for unresected soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 2005;63(3):852-9. (Pubitemid 41400075)
58. Schwarz R, Krüll A, Engenhart-Cabillic R, Favre A, Prott FJ, Auberger T, et al. European results of neutron therapy in soft tissue sarcomas, Recent Results Cancer Res 1998;150:100-12.
59. Greiner R, Munkel G, Kann R, Blattmann H, Coray A, Thum P, et al. Pion irradiation at Paul Scherrer Institute. Results of dynamic treatment of unresectable soft tissue sarcoma. Strahlenther Onkol 1990;166(1):30-3. (Pubitemid 20086300)
60. Hug EB, Loredo LN, Slater JD, De Vries A, Grove RI, Schaefer RA, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999;91(3):432-9. (Pubitemid 29404435)
61. Debus J, Schulz-Ertner D, Schad L, Essig M, Rhein B, Thillmann CO, et al. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 2000;47(3):591-6. (Pubitemid 30317475)
62. Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Jäkel O, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 2007;68(2):449-57. (Pubitemid 46694169)
63. Schuetze SM, Patel S. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy? Oncologist 14(10):1003-12.
64. Blay JY, Le Cesne A. Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven. Oncologist 2009;14(10):1013-20.
65. Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults. metaanalysis of individual data. Lancet 1997;350(9092):1647-54.
66. Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma Cancer 2008;113(3):573-81.
67. Frustaci S, Gherlinzoni F, De Paoli A, Bonetti M, Azzarelli A, Comandone A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 2001;19(5):1238-47. (Pubitemid 32202526)
68. Bramwell V, Rouesse J, Steward W, Santoro A, Schraffordt-Koops H, Buesa J, et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma - reduced local recurrence but not improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994;12(6):1137-49.
69. Woll PJ, van Glabbeke M, Hohenberger P, Le Cesne A, Gronchi A, Hoeksta HJ, et al. Adjuvant chemotherapy (CT) with doxorubicin and ifosfamide in resected soft tissue sarcoma (STS): Interim analysis of a randomised phase III trial. J Clin Oncol 2007;25(18 S):Abstract 10008.
70. Kattan MW, Leung D H Y, Brennan MF: Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002;20:791-6. (Pubitemid 34111387)
71. Mariani L, Miceli R, Kattan MW, Brennan MF, Colecchia M, Fiore M, et al. Validation and adaptation of a nomogram for predecting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 2005;103:402-8. (Pubitemid 40129301)
72. Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, et al. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: A european organisation for research and treatment of cancer soft tissue and bone sarcoma group study. J Clin Oncol 2007;25:3144-50. (Pubitemid 47218064)
73. Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: A randomized study of the european organisation for research and treatment of cancer soft tissue and bone sarcoma group. J Clin Oncol 1995;13:1537-45.
74. Morgan JA, Le Cesne A, Chawla S, von Mehren M, Schuetze S, Casali PG, et al. Randomized phase II study of trabectedin in patients with liposarcoma and leiomyosarcoma (L-sarcomas) after failure of prior anthracyclines (A) and ifosfamide (I). J Clin Oncol 2007. ASCO Annual Proceedings Part I, 25(18S): Abstract 10060.
75. Garcia-Carbonero R, Supko JG, Manola J, Seiden M V, Harmon D, Ryan DP, et al. Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy. J Clin Oncol 2004;22(8):1480-90. (Pubitemid 41103631)
76. Yovine A, Riofrio M, Blay JY, Brain E, Alexandre J, Kahatt C, et al. Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients. J Clin Oncol 2004;22(5):890-9. (Pubitemid 41103601)
77. Le Cesne A, Blay JY, Judson I, Van Oosterom A, Verweij J, Radford J, et al. Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial. J Clin Oncol 2005;23(3):576-84. (Pubitemid 46224235)
78. Demetri GD, Chawla SP, von Mehren M, Ritch P, Baker LH, Blay JY, et al. Efficacy and Safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: Results of a randomized phase II study of two dif erent schedules. J Clin Oncol 2009;27(25):4188-96.
79. Hensley ML, Maki R, Venkatraman E, Geller G, Lovegren M, Aghajanian C, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 2002;20(12):2824-31. (Pubitemid 34651511)
80. Leu KM, Ostruszka LJ, Shewach D, Zalupski M, Sondak V, Biermann JS, et al. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. J Clin Oncol 2004;22(9):1706-12. (Pubitemid 41079810)
81. Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002. J Clin Oncol 2007;25(19):2755-63. (Pubitemid 47123184)
82. Maki RG, D'Adamo DR, Keohan ML, Saulle M, Schuetze SM, Undevia SD, et al. Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol 2009;27(19):3133-40.
83. Ryan CW, von Mehren M, Rankin CJ, Goldblum JR, Demetri GD, Bramwell VH, et al. Phase II intergroup study of sorafenib (S) in advanced soft tissue sarcomas (STS): SWOG 0505. J Clin Oncol 2008;26(Suppl.):Abstract 10532.
84. George S, Merriam P, Maki RG, Van den Abbeele AD, Yap JT, Akhurst T, et al. Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas. J Clin Oncol 2009;27(19):3154-60.
85. Agulnik M, Okuno SH, Von Mehren M, Jovanovic B, Brockstein B, Benjamin RS, et al. An open-label multicenter phase II study of bevacizumab for the treatment of angiosarcoma. J Clin Oncol 2009;27(Suppl.):Abstract 10522.
86. Pink D, Rahm J, Schoeler D, Schoenknect TM, Reichardt P. Activity of paclitaxel in radiation induced and other secondary angiosarcomas. J Clin Oncol 2009;27(Suppl.):Abstract 10578.
87. Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study. J Clin Oncol 2008;26:5269-74.
88. NCCN Clinical Practice Guidelines in Oncology: Soft Tissue Sarcoma. Version 1. 2011.
89. Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, et al. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 2009;88:877-85.
90. Issels RD. High-risk soft tissue sarcoma. clinical trial and hyperthermia combined chemotherapy. Int J Hyperthermia 2006;22(3):235-9. (Pubitemid 43878684)
91. Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BD, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. The Lancet Oncology 2010;11(6):561-70.
92. Lahat G, Anaya DA, Wang X, Tuvin D, Lev D, Pollock RE. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Ann Surg Onocl 2008;15(6):1585-93.
93. Engström K, Bergh P, Gustafson P, Hultborn R, Johansson H, Löfvenberg R, et al. Liposarcoma. outcome based on the Scandinavian Sarcoma Group register. Cancer 2008;113(7):1649-56.
94. Lehnert T, Cardona S, Hinz U, Willeke F, Mechtersheimer G, Treiber M, et al. Primary and locally recurrent retroperitoneal soft-tissue sarcoma: local control and survival. Eur J Surg Oncol 2009;35(9):986-93.
95. Stojadinovic A, Leung DH, Hoos A, Jaques DP, Lewis JJ, Brennan M F. Analysis of the prognostic significance of microscopic margins in 2.084 localized primary adult soft tissue sarcomas. Ann Surg 2002;235(3):424-34. (Pubitemid 34183894)
96. Anaya DA, Lahat G, Liu J, Xing Y, Cornier JN, Pisters PW, Lev DC, et al. Multifocality in retroperitoneal sarcoma. A prognostic factor critical to surgical decision-making. Ann Surg 2009;249(1):137-42.
97. Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY, et al. Primary retroperitoneal sarcomas. A multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009;27(1):31-37.
98. Sampath S, Hitchcock YJ, Shrieve DC, Randall RL, Schultheiss TE, Wong JY. Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: Multi-institutional analysis of 261 patients. J Surg Oncol 2010; Jan 29 (Epub ahaed of print).
99. Petersen IA, Haddock MG, Donohue JH, Nagorney DM, Grill J P, Sargent DJ, et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2002;52(2):469-75. (Pubitemid 34170851)
100. Dziewirski W, Rutkowski P, Nowecki Zl, Salamacha M, Morysinski T, Kulik A, et al. Surgery combined with intraoperative brachytherapy in the treatment of retroperitoneal sarcomas. Ann Surg Oncol 2006;13(2):245-52. (Pubitemid 43157420)
101. Zacherl M, Leithner A, Koch H, Windhager R. Weichteilsarkome - jeder zweite Patient inadäquat therapiert. Wiener Klin Magazin 2006;1:22-8.
102. Zacherl M, Giessauf C, Glehr M, Gruber G, Maurer-Ertl W, Schwantzer G, et al. Revision of inadequately treated softtissue sarcoma is associated with increased need for plastic or reconstructive surgery. Eur Surg 2009;41(4):155-62.
103. Candrasekar CR, Wafa H, Grimer RJ, Carter SR, Tillman RM, Abudu A. The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg Br 2008;90(2):203-8. (Pubitemid 351303348)
104. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy Cancer 2003;97 (10);2544-53.
105. Zagars GK, Ballo MT. Sequencing radiotherapy for soft tissue sarcoma when re-resection is planned. Int J Radiat Oncol Biol Phys 2003;56(1):21-7. (Pubitemid 36403673)
106. Kepka L, Suit HD, Goldberg SI, Rosenberg AE, Gebhardt MC, Hornicek FJ, et al. Results of radiation therapy performed after unplanned surgery (without re-excision) for soft tissue sarcomas. J Surg Oncol 2005;92(1):39-45. (Pubitemid 41416427)
107. Funovics PT, Vaselic S, Panotopoulos J, Kotz RI, Dominkus M. The impact of re-excision of inadequately resected soft tissue sarcomas on surgical therapy, results and prognosis: a single institution experience with 682 patients. J Surg Oncol 2010;102(6):626-33.
108. Patel SR, Zagars GK, Pisters PW. The follow-up of adult softtissue sarcomas. Semin Oncol 2003;30(3):413-6.